Brain Cancer section

Brain Cancer News and Features

Potential therapy found for incurable pediatric brain tumor

Scientists have developed a new potential drug therapy for a rare, incurable pediatric brain tumor by targeting a genetic mutation found in children with the cancer.

Chemotherapy after radiation slows progression of low-grade gliomas

A chemotherapy regimen of procarbazine, lomustine (CCNU), and vincristine (PCV) administered after radiation therapy improved both progression-free survival and overall survival in adults with low-grade gliomas.

Collaboration yields new methods to treat tumors with antennas

Two engineering researchers have challenged a commonly held idea about tumor ablation.

Survivors of childhood central nervous system cancer show affected self-identity

Survivors of childhood central nervous system cancer show affected self-identity

Patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception later in adulthood.

Wireless phone may increase risk of gliomas

Wireless phone may increase risk of gliomas

Risk of brain cancer is three times higher after 25 years or more of mobile phone use.

Brain Cancer Videos

Brain Cancer Clinical Trials

Adding ovarian suppression to tamoxifen reduced recurrence for some premenopausal breast cancer

Among premenopausal women with early stage, HR-positive breast cancer, the addition of ovarian suppression to tamoxifen reduced breast cancer recurrence.

Tamoxifen found to lower breast cancer rates among high-risk women in trial

The International Breast Cancer Intervention Study-I (IBIS-I) trial found that tamoxifen significantly decreased the incidence of all breast cancers, according to data presented at the 2014 San Antonio Breast Cancer Symposium.

Pembrolizumab safe, and even effective in some patients, for triple-negative breast cancer

Pembrolizumab was well tolerated and yielded durable responses in patients with metastatic triple-negative breast cancer, according to recent trial data.

Rociletinib produces response in treatment-resistant advanced non-small cell lung cancer (NSCLC)

A new drug that targets common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), and a type of the mutation responsible for treatment resistance, has shown promising results in a phase I/II clinical trial.

IDH1 mutation inhibitor first to demonstrate anticancer activity

The first drug designed to inhibit the cancer-causing activity of a mutated enzyme known as isocitrate dehydrogenase (IDH) 1 has shown clinical activity in patients with advanced acute myeloid leukemia (AML) with the IDH1 mutation.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs